Overview

Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The progression free survival could be prolonged adding pseudomonas aeruginosa to monotherapy capecitabine.
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Treatments:
Capecitabine